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Compostos (E)-1,2-dibromo vinílicos 11a-f foram preparados estereosseletivamente via reação
de bromação de alcinos empregando-se tribrometo de piridínio em MeOH/CCl4 a baixa temperatura
e utilizados na reação de duplo acoplamento com PhZnCl catalisada por Pd(0), segundo protocolo
de Negishi, fornecendo as respectivas olefinas tri e tetrassubstituídas 14a-e. Tamoxifeno, um
agente antiestrogênico de uso clínico na terapia do câncer de mama, foi preparado na forma de
uma mistura Z:E de proporção 2.3:1, em 7 etapas em um rendimento global de 30% a partir do
4-iodofenol (3).
(E)-1,2-vinylic dibromides 11a-f were stereoselectively prepared via bromination of acetylenic
compounds with pyridinium tribromide in MeOH/CCl4 at low temperature and double cross-
coupled with PhZnCl under Pd(0) catalysis (Negishi protocol) to afford tri- and tetrasubstituted
olefins 14a-e. Tamoxifen, a selective estrogen receptor modulator clinically prescribed in breast
cancer therapy, was prepared in 7 steps and 30% overall yield from 4-iodophenol (3) as a 2.3:1
mixture of (Z)- and (E)-isomers.
Keywords: (E)-1,2-vinylic dibromides, double cross-coupling, palladium catalysis, tri- and
tetrasubstituted olefins, tamoxifen
Introduction
The stereoselective synthesis of tri- and tetrasubstituted
olefins is of great interest in the domain of biologically
active compounds where the E and Z isomers may have
completely different biological properties as represented
by tamoxifen, a tetrasubstituted stilbene which acts as a
selective estrogen receptor modulator (SERM): while (Z)-
tamoxifen (1) displays antiestrogenic activity and is
prescribed as the corresponding citrate as an adjuvant for
breast cancer therapy, (E)-isomer 2 has estrogenic activity
and stimulates the proliferation of hormone-responsive
breast cancer cells (Figure 1).1 Methods are available for
the separation of (E)- and (Z)-isomers as well as for
isomerization of estrogenic (E)-tamoxifen (2)2 to
antiestrogenic (Z)-tamoxifen (1),3-5 including large scale
operations. Among the routes already described in the
literature, the method by Knochel and coworkers6 is by far
the more efficient one: starting from 1-phenyl-1-butyne,
(Z)-tamoxifen (1) is prepared in three steps and 71% yield
via Ni(II)-catalyzed syn carbozincation, followed by
Negishi coupling of the corresponding vinylic iodide with
4-triisopropylsililoxyphenylzinc bromide.
Despite the different approaches already reported for
the stereoselective synthesis of tamoxifen (dehydration,4
McMurry5 and metal-catalyzed coupling protocols6-13), we
were attracted by the possibility of preparing (Z)-tamoxifen
(1) from the corresponding (E)-1,2-vinylic dibromide via
an one-pot tandem coupling with a phenylorganometallic
species with retention of configuration.
1,2-Dihaloalkenes are potentially useful starting
materials for the preparation of tri- and tetrasubstituted
olefins via transition metal catalyzed cross-coupling with
organometallic species.14 Accordingly, Rossi and
coworkers15 described the utilization of tetrasubstituted (E)-
Figure 1. Structures of (Z)-tamoxifen (1) and (E)-tamoxifen (2).
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2,3-dibromopropenoates in the palladium-catalyzed cross-
coupling with aryl and alkynylzinc species. The
stereoselectivity of these reactions was found to be
dependent upon the substituent present at C-3 of the
propenoates.
Results and Discussion
Due to the availability of E-1,2-dibromoalkenes from
the bromination of the corresponding acetylenes, we were
attracted to the possibility of preparing (Z)-tamoxifen (1)
from (E)-9 via the palladium-catalyzed tandem cross-
coupling with phenylzinc chloride (Scheme 1).
4-Iodophenol (3) was straightforwardly protected as the
corresponding chloroethylether 4 before the Sonogashira
coupling with trimethylsilylacetylene which afforded
acetylene 5 in 99% yield. TMS-deprotection followed by
alkylation of the terminal acetylene 6 with ethyl iodide
provided disubstituted acetylene 7 (83% yield, 2 steps).
At this juncture, the stereoselective conversion of 7 to
the corresponding (E)-dibromoalkene 8 was needed. While
our preliminary attempts with molecular bromine in either
CHCl3 or CCl4 afforded mixtures of (E)- and (Z)-1,2-
dibromoalkenes as well as the corresponding
tribromoderivatives when alkylacetylenes were employed,
the use of pyridinium tribromide16 in a 1:1 mixture of CCl4-
MeOH at –10 oC provided (E)-1,2-dibromoalkene 8 in 86%
yield without formation of the corresponding 1,1-dibromo-
2,2- dimethoxyalkane as previously reported when the
reaction was carried out in methanol.17 The protocol above
proved to be equally efficient for the bromination of either
alkyl- or aryl-substituted alkynes 10a-f (Table 1). The
(E)-configuration of 1,2-dibromo alkenes 11a-e was
assigned based on literature data18 while the stereochemistry
of 11f was assumed by analogy.
With a stereoselective route to (E)-9 secured, we
explored its Pd(0)-catalyzed double cross-coupling with
PhZnCl (8 equiv.) generated in situ by transmetallation of
a 0.5 mol L-1 solution of phenyllithium in THF with ZnCl2.
The cross-coupling was carried out in refluxing toluene
with 10 mol% of Pd(PPh3)4 and afforded a 2.3:1 mixture
of (Z)-tamoxifen (1) and (E)-tamoxifen (2) in 52% yield.19
The diastereoisomeric ratio was determined by capillary
GC analysis and the configuration of the major
diastereoisomer established by comparison of the NMR
data of the synthetic mixture with an authentic sample of
(Z)-tamoxifen (1). The loss of stereochemical integrity
during the Pd(0)-catalyzed cross-coupling is reminiscent
of the observations by Rossi and coworkers15 who described
similar behavior during the cross-coupling of
tetrasubstituted (E)-2,3-dibromopropenoates with arylzinc
chlorides. However, Rathore and coworkers described that
the Pd(0)-catalyzed coupling of aryl Grignard reagents
bearing ortho methyl groups and (E)-1,2-dibromoalkenes
efficiently provides (Z)-tetrasubstituted alkenes.20
Table 1. Bromination of alkynes 10a-f with PyHBr3 in CCl4/MeOH at –
10 ºC
Entry R1 R2 (E)-11 (%)a 12 (%)a
10a HOCH2- H 86 -
10b HOCH2- Me 78 -
10c Ph H 83 12c (trace)
10d Ph Et 81 12d (trace)
10e Ph Ph 86 -
10f H 85 12f (10)
aYields after column chromatography on silica gel.
Scheme 1. Reagents and Conditions: a) 1,2-dichloroethane, Bu4N(HSO4), NaOH(aq), reflux, 5h, 91%; b)trimethylsilylacetylene, (PPh3)2PdCl2 (5 mol%),
CuI (4 mol%), Et3N, rt, 5h, 99%; c) MeOH, 1 N aq. KOH, rt, 2h, 92%; d) n-BuLi, THF, -78ºC, 15 min, then EtI, DMPU, -78ºC to rt, 90%; e)PyHBr3,
CCl4/MeOH (1:1), -10 ºC, 40 min, 86%; f) N,N-dimethylamine, EtOH, 90 ºC, 72h, 91%; g) PhZnCl (8 eq), Pd(PPh3)4 (10 mol%), toluene, reflux, 24h,
52%.
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While (Z)-tamoxifen (1) is formed through a double
Negishi coupling, the competitive formation of (E)-tamoxifen
(2) seems to involve syn-carbopalladation of alkyne 13 which
is observed to be formed from (E)-9 (GC analyses) under the
reaction conditions employed (Scheme 2). In fact, although
attempts to carry out Pd(0)-catalyzed coupling with alkyne
13 under the reaction conditions employed failed, we were
able to observe exclusive formation of (E)-tamoxifen (2) when
13 was treated with Pd(PPh3)4/PhBr, followed by addition of
PhZnCl (Scheme 2).
We have also examined the formation of tri- and
tetrasubstituted olefins 14a-e from the corresponding
(E)-11a-e. As depicted in Table 2, in all cases good yields
of the corresponding tri- and tetrasubstituted olefins 14a-e
were obtained with retention of the double bond
configuration being observed when alkyl substituted
1,2-dibromo alkenes (E)-11a,b were employed.
The low level of diastereoselection reported in the double
Negishi coupling of vinylic dibromide (E)-9 with phenylzinc
chloride calls for a more efficient catalytic system in order
to carry out the coupling reaction. The highest stereoselective
methodologies described so far in the literature for the total
synthesis of (Z)-tamoxifen (1) rely on either syn
carbometallation,6,12 hidroxymethyl directed anti
carbometallation11 or anti stannylcupration.8 However, when
Table 2. Pd(0)-catalyzed double cross-coupling of dibromo alkenes (E)-
11a-e with PhZnCl
(E)-11 R1 R2 Conditionsa 14 (%)
a HOCH2- H A 78
b HOCH2- Me A 68
c Ph H A 68
d Ph Et A 70
e Ph Ph B 78
aA: 10 mol% Pd(PPh3)4, THF, rt; B: 10 mol% Pd(PPh3)4, toluene, reflux.
Scheme 2. Competitive pathways for (Z)- and (E)-tamoxifen (1 and 2).
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compared with the routes based on dehydration4 or McMurry
coupling,5 the results described herein display about the same
level of diastereoselection. Considering the availability of
methods for separation of (E)- and (Z)-tamoxifen and for
the interconversion of (E)- to (Z)-tamoxifen, our results are
an useful asset to those already known as it allows the
preparation of tamoxifen as a 2.3:1 mixture of Z- and
E-isomers in 7 steps and 30% overall yield from
commercially available 4-iodophenol (3).
Experimental
General
All reactions of air- and water-sensitive materials were
performed in flame dried glassware under an atmosphere
of argon. Triethylamine was distilled from CaH2,
tetrahydrofuran was previously treated with CaH2 and
distilled from sodium, toluene was distilled from sodium.
DMPU and bromobenzene were previously treated with
CaH2, distilled from CaH2 and stored over molecular sieves.
4-iodophenol (3), 1,2-dichloroethane,trimethylsilyl-
acetylene,dichloro(triphenylphosphine)palladium(II), ethyl
iodide, pyridinium tribromide, tetrakis(triphenylphosphine)
palladium(0) and alkynes 10a-e were commercially
available. The compounds were purified by column
chromatography on silica gel (70-230 mesh). The 1H-NMR
and 13C-NMR spectra were recorded on a Varian Gemini
(7.05T), Varian Inova (11.7T) spectrometers. Chemical
shifts (δ) are recorded in ppm with the solvent resonance
as the internal standard and coupling constants (J) recorded
in Hz. The infrared spectra were recorded as films in KBr
cells on a Nicolet Impact 410 (FTIR). High resolution mass
spectroscopy (HRMS) were performed on a VG Autoespec-
Micromass-EBE. The melting points were measured on
an Electrothermal 9100 apparatus. The gas chromatography
analyses (FID detector) were performed using a Hewlett
Packard 5890-II equipament. Gas chromatography-mass
spectrometry (GC-MS) analyses were performed on a
Hewlett Packard 5890/ Hewlett Packard 5970 MSD.
1-(2-Chloroethoxy)-4-iodobenzene, (4)8
To a solution of 4-iodophenol (3) (2.09 g, 95.0 mmol)
and tetrabutylammonium hydrogensulfate (160 mg, 0.47
mmol) in 1,2-dichloroethane (10 mL, 0.90 mol) was added
3 mol L-1 aqueous sodium hydroxide (5.5 mL) and the
mixture was refluxed for 1h after which 6 mol L-1 aqueous
sodium hydroxide (1.0 mL) was added. The resulting
solution was refluxed for 24 h and cooled to room
temperature. The organic layer was separated, diluted with
petroleum ether (30 mL) and extracted with saturated
aqueous ammonium chloride (3 x 10 mL). The organic
layer was dried with anhydrous MgSO4 and concentrated
under reduced pressure. The crude product was purified
by column chormatography (hexane:ethyl acetate, 9:1)
affording chloroethylether 4 (3.30 g, 86.4 mmol) in 91%
yield as a white solid, mp: 56.8-57.2 ºC. 1H-NMR (300
MHz, CDCl3) δ 3.78 (2H, t, J 5.9 Hz), 4.20 (2H, t, J 5.9
Hz), 6.68 (2H, d, J 8.4 Hz), 7.55 (2H, d, J 8,4 Hz). 13C-
NMR (75 MHz, CDCl3) δ 41.6 (CH2), 68.1 (CH2), 83.6
(C), 117.8 (CH), 136.4 (CH), 158.1 (C). IR (KBr film)
ν
max
/cm-1: 3082, 2958, 2931, 2870, 1587, 1487, 1454, 1254,
1117, 1036, 829, 814, 669.
2-Chloroethyl 4-(trimethylsilylethynyl)phenyl ether, (5)
To a solution of 4 (1.42 g, 5.03 mmol) and
trimethylsilylacetylene (0.87 mL, 6.01 mmol) in dry
triethylamine (20.0 mL) at room temperature was added
dichloro(triphenylphosphine)palladium(II) (187 mg, 0.25
mmol) and copper(I) iodide (53.0 mg, 0.23 mmol) under
argon atmosphere. After 2 h the reaction mixture was
concentrated under reduced pressure and was purified by
column chromatography (hexane:ethyl acetate, 9:1)
affording 5 (1.26 g, 5.02 mmol) in 99% yield as a white
solid, mp: 44.2-44.4 ºC. 1H-NMR (500 MHz, CDCl3) δ
0.24 (9H, s), 3.80 (2H, t, J 5.8 Hz), 4.21 (2H, t, J 5.8 Hz),
6.82 (2H, d, J 8.7 Hz), 7.41 (2H, d, J 8,7 Hz). 13C-NMR
(125 MHz, CDCl3) δ 0.2 (CH3), 42.8 (CH2), 68.0 (CH2),
92.8 (C), 104.8 (C), 114.4 (C), 116.0 (CH), 133.4 (CH),
158.1 (C). IR (KBr film) ν
max
/cm-1: 3043, 2964, 2896, 2158,
1604, 1506, 1250, 1176, 1038, 869, 843, 761. GC-MS (EI)
m/z 254(12%), 252(37%), 237(100%). HRMS (EI): Found:
252.07044; Calc. For: C18H17SiOCl: 252.07072.
2-Chloroethyl 4-ethynylphenyl ether, (6)
To a solution of 5 (1.26 g, 5.00 mmol) in methanol
(10.0 mL) at room temperature was added 1 mol L-1
aqueous potassium hydroxide (8 mL). After 2 h diethyl
ether (30 mL) was added and the layers were separated.
The aqueous phase was extracted with Et2O (2 x 15 mL)
and the combined organic phase was extracted with brine,
dried over anhydrous MgSO4 and concentrated under
reduced pressure. The crude product was purified by
column chromatography (hexane:ethyl acetate, 8:2)
affording 6 (840 mg, 4.67 mmol) in 92% yield as a yellow
solid, mp: 53.2-53.6 ºC. 1H-NMR (300 MHz, CDCl3) δ
3.02 (1H, s), 3.81 (2H, t, J 5.9 Hz), 4.22 (2H, t, J 5.9 Hz),
6.85 (2H, d, J 8.8 Hz), 7.43 (2H, d, J 8,8 Hz). 13C-NMR
(75 MHz, CDCl3) δ 41.7 (CH2), 68.0 (CH2), 76.6 (CH),
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83.4 (C), 114.5 (C), 114.5 (CH), 133.5 (CH), 158.1 (C).
IR (KBr film) ν
max
/cm-1: 3290, 3043, 2966, 2925, 2872,
2109, 1604, 1504, 1240, 1035, 829. GC-MS (EI) m/z
182(32%), 180(95%), 118(100%). HRMS (EI): Found:
180.03876; Calc. for: C10H9ClO: 180.03419.
4-(But-1-yn-1-yl)phenyl 2-chloroethyl ether, (7)
To a solution of 6 (704 mg, 3.91 mmol) in dry THF
(15.0 mL) at –78 ºC was added a 1.52 mol L-1 solution of
n-butyllithium in hexanes (3.10 mL, 4.71 mmol). The
mixture was stirred at –78 ºC for 20 min, under argon
atmosphere, followed by slow addition of a solution of ethyl
iodide (0.38 mL, 4.69 mmol) in DMPU (1.0 mL). After
completed addition, the temperature was raised to rt. After
2 h the reaction mixture was quenched with 1% aqueous
HCl and the layers were separated. The aqueous phase was
extracted with Et2O (3 x 20 mL) and the combined organic
phase was extracted with brine, dried over anhydrous
MgSO4 and concentrated under reduced pressure. The
crude product was purified by column chromatography
(hexane:ethyl acetate, 9:1) affording 7 (732 mg, 3.48 mmol)
in 90% yield as a white solid, mp: 52.4-52.6 ºC. 1H-NMR
(300 MHz, CDCl3) δ 1.22 (3H, t, J 7.3 Hz), 2.40 (2H, q, J
7.3 Hz), 3.80 (2H, t, J 5.9 Hz), 4.21 (2H, t, J 5.9 Hz), 6.82
(2H, d, J 8.8 Hz), 7.32 (2H, d, J 8,8 Hz). 13C-NMR (75
MHz, CDCl3) δ 13.2 (CH3), 14.1 (CH2), 41.8 (CH2), 67.9
(CH2), 79.3 (C), 90.3 (C), 114.4 (C), 116.9 (CH), 132.8
(CH), 157.3 (C). IR (KBr film) ν
max
/cm-1: 3058, 2964, 2920,
2872, 1611, 1514, 1460, 1303, 1255, 1113, 1040, 837, 828,
673. GC-MS (EI) m/z 210(33%), 208(100%), 131(50%).
HRMS (EI): Found: 208.06642; Calc. for: C12H13ClO:
208.06549.
2-Chloroethyl 4-[(1E)-1,2-dibromobut-1-en-1-yl]phenyl
ether, ((E)-8)
To a solution of alkyne 7 (318 mg, 1.53 mmol) in CCl4
(7.5 mL) at –10 ºC was added pyridinium tribromide (575
mg, 1.80 mmol) followed by slow addition of MeOH (5.0
mL). The reaction mixture was kept at –10 oC for 45 min
and quenched with 10% aqueous sodium thiosulfate. The
organic layer was separated, extracted with brine, dried
with anhydrous MgSO4 and concentrated under reduced
pressure. The crude mixture was chromatographed on silica
gel (hexane:ethyl acetate, 9:1) affording (E)-8 (502 mg,
1.37 mmol) in 86% yield as a yellow solid, mp: 65.6-66.0
ºC. 1H-NMR (300 MHz, CDCl3,) δ 1.22 (3H, t, J 7.3 Hz),
2.84 (2H, q, J 7.3 Hz), 3.82 (2H, t, J 5.9 Hz), 4.24 (2H, t, J
5.9 Hz), 6.86 (2H, d, J 8.8 Hz), 7.31 (2H, d, J 8,8 Hz). 13C-
NMR (75 MHz, CDCl3) δ 12.1 (CH3), 35.2 (CH2), 41.8
(CH2), 67.9 (CH2), 114.2 (C), 115.5 (C), 124.7 (C), 130.8
(CH), 134.0 (CH), 158.1 (C). IR (KBr film) ν
max
/cm-1: 3047,
2979, 2935, 2876, 1604, 1508, 1454, 1246, 1176, 1038,
833, 791. GC-MS (EI) m/z 372(8%), 370(1%), 368(61%),
366(25%), 291(23%), 289(100%), 287(76), 208(85%),
145(56%), 115(31%). HRMS (EI): Found 367.90028; Calc.
for C12H13Br2ClO: 367.90003.
General procedure for the bromination of alkynes 10a-f
with PyHBr3 (Table 1)
To a solution of alkyne 10a-f (1.00 mmol) in CCl4 (5.0
mL) at –10 ºC pyridinium tribromide (1.20 mmol) was
added, followed by MeOH (5.0 mL). The reaction mixture
was kept at –10 oC for 30-60 min and quenched with 10%
aqueous sodium thiosulfate. After extraction with CH2Cl2,
the combined organic phase was extracted with brine and
dried over anhydrous MgSO4. The crude mixture was
chromatographed on silica gel to afford dibromo alkenes
11a-f.
(E)-2,3-Dibromoprop-2-en-1-ol, ((E)-11a).18 Colorless
oil. 1H-NMR (300 MHz, CDCl3) δ 2.15 (1H, t, J 6.7 Hz),
4.47 (2H, d, J 6.6 Hz), 6.57 (1H, s). 13C-NMR (75 MHz,
CDCl3) δ 63.9 (CH2), 104.1 (CH), 125.2 (C). IR (KBr film)
ν
max
/cm-1: 3348, 3082, 2924, 2866, 1608, 1446, 1227, 1053,
960, 795, 706.
(E)-2,3-Dibromobut-2-en-1-ol, ((E)-11b).18 White solid,
mp: 38.3-38.7 ºC. 1H-NMR (300 MHz, CDCl3) δ 2.34 (1H,
t, J 6.7 Hz), 2.43 (3H, s), 4.48 (2H, d, J 6.6 Hz). 13C-NMR
(75 MHz, CDCl3,) δ 28.8 (CH3), 67.4 (CH2), 117.8 (C),
120.7 (C). IR (KBr film) ν
max
/cm-1: 3356, 2924, 2870, 1639,
1426, 1084, 1022.
[(E)-1,2-Dibromovinyl]benzene, ((E)-11c).18 White
solid, mp: 72.2-73.2 ºC. 1H-NMR (300 MHz, CDCl3) δ
6.76 (1H, s), 7.26-7.39 (3H, m), 7.48-7.52 (2H, m). 13C-
NMR (75 MHz, CDCl3) δ 103.3 (CH), 121.2 (C), 128.2
(C), 129.0 (CH), 129.3 (CH), 136.9 (C). IR (KBr film)
ν
max
/cm-1: 3082, 2930, 2847, 1592, 1489, 1450, 1167, 874.
 [(E)-1,2-Dibromobut-1-en-1-yl]benzene, ((E)-11d).18
Yellow oil. 1H-NMR (300 MHz, CDCl3) δ 1.23 (3H, t, J
7.3 Hz), 2.86 (2H, q, J 7.3 Hz), 7.32-7.36 (5H, m). 13C-
NMR (75 MHz, CDCl3) δ 12.1 (CH3), 35.1 (CH2), 115.5
(C), 124.8 (C), 128.2 (C), 128.5 (CH), 129.1(CH), 140.8
(C). IR (KBr film) ν
max
/cm-1: 3059, 2974, 2931, 2873, 1489,
1450, 1215, 1111, 868, 795, 756.
[(E)-1,2-Dibromobut-1-en-1-yl]benzene, ((E)-11e).18
White solid, mp: 209.5 ºC. 1H-NMR (300 MHz, CDCl3) δ
7.32-7.40 (3H, m), 7.43-7.48 (2H, m). 13C-NMR (75 MHz,
CDCl3) δ 118.1 (C), 128.4 (CH), 128.9 (CH), 129.1 (CH),
140,7 (C).
2-Chloroethyl 4-[(E)-1,2-dibromovinyl]phenyl ether,
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((E)-11f). Colorless oil. 1H-NMR (300 MHz, CDCl3) δ 3.82
(2H, t, J 5.9 Hz), 4.26 (2H, t, J 5.9 Hz), 6.74 (1H, s), 6.91
(2H, d, J 8.8 Hz), 7.48 (2H, d, J 8.8 Hz). 13C-NMR (75
MHz, CDCl3) δ 41.7 (CH2), 67.9 (CH2), 102.2 (CH), 114.2
(C), 121.1 (C), 129.4 (CH), 130.9 (CH), 158.7 (C). IR (KBr
film) ν
max
/cm-1: 3080, 2960, 2923, 2867, 1603, 1502, 1246,
1036, 831, 688. GC-MS (EI) m/z 344(5%), 342(28%),
340(44%), 338(17%), 263(25%), 261(100%), 259(84%),
180(69%), 118(94%). HRMS (EI): found 339.86859, calc
for C10H9Br2ClO: 339.86872.
2-{4-[(1E)-1,2-Dibromobut-1-en-1-yl]phenoxy}-N,N-
dimethylethanamine, ((E)-9)
A solution of vinylic dibromide (E)-8 (63 mg, 0.17
mmol) in ethanolic N,N-dimethylamine (30% v/v, 2.0 mL)
was refluxed for 72 h. The resulting reaction mixture was
cooled to room temperature, quenched with 1 mol L-1
aqueous sodium hydroxide (5.0 mL) and diethyl ether (5.0
mL) was added and the layers were separated. The aqueous
phase was extracted with diethyl ether (3 x 10 mL) and the
combined organic phase was extracted with brine, dried
over anhydrous MgSO4 and concentrated under reduced
pressure. The crude mixture was chromatographed on silica
gel (hexane:ethyl acetate, 7:3) affording (E)-9 (58 mg, 0.15
mmol) in 91% yield as a yellow oil. 1H-NMR (300 MHz,
CDCl3) δ 1.22 (3H, t, J 7.3 Hz), 2.34 (6H, s), 2.74 (2H, t, J
5.9 Hz), 2.84 (2H, q, J 7.3 Hz), 4.08 (2H, t, J 5.9 Hz), 6.88
(2H, d, J 8.4 Hz), 7.27 (2H, d, J 8,4 Hz). 13C-NMR (75
MHz, CDCl3) δ 12.2 (CH3), 35.3 (CH2), 45.9 (2 x CH3),
58.2 (CH2), 66.0 (CH2), 114.4 (C), 115.7 (C), 124.3 (C),
130.5 (CH), 133.1 (CH), 158.6 (C). IR (KBr film) ν
max
/cm-
1: 2970, 2935, 2819, 2769, 1604, 1508, 1246, 1173, 1034,
833, 767. GC-MS (EI) m/z 379(1%), 377(2%), 375(1%),
58(100). HRMS (EI): Found 376.98162; Calc. for
C14H19Br2NO: 376.98135.
Palladium-catalysed double cross-coupling of (E)-9 with
PhZnCl: Synthesis of (Z)-tamoxifen, (1) and (E)-tamoxifen, (2)
To a solution of bromobenzene (84 µL, 0.80 mmol) in
dry THF (1.0 mL) at –78 ºC was added a 1.73 mol L-1 solution
of n-buthyllythium in hexanes (74 µL, 0.82 mmol). After
15 min, a solution of ZnCl2 (122 mg, 0.90 mmol) in dry
THF (2.0 mL) was added and the resulting mixture was
allowed to warm to room temperature. After 30 min, a
solution of (E)-9 (38 mg, 0.10 mmol) in dry THF (2 mL)
containing a catalytic amount of tetrakis(triphenyl-
phosphine)palladium(0) (12 mg, 0.010 mmol) was added.
To the resulting mixture was added toluene (10.0 mL) and
the solution was refluxed for 24 h and cooled to room
temperature. The resultant reaction mixture was quenched
with saturated aqueous ammonium chloride (5.0 mL) and
extracted with Et2O (3 x 20 mL). The combined organic
phase was washed with brine, dried over anhydrous MgSO4
and concentrated under reduced pressure. The crude mixture
was chromatographed on silica gel (CHCl3:MeOH, 9:1)
affording a 2.3:1 mixture of (Z)-tamoxifen (1) and (E)-
tamoxifen (2) in 52% yield. 1H-NMR (300 MHz, CDCl3) δ
0.91 (Z isomer. 3H, t, J 7.3 Hz), 0.94 (E isomer. 3H, t, J 7.3
Hz), 2.28 (Z isomer. 6H, s), 2.34 (E isomer. 6H, s), 2.42-2.52
(Z and E isomers. 4H, m), 2.63 (Z isomer. 2H, t, J 5.9 Hz),
2.74 (E isomer. 2H, t, J 5.9 Hz), 3.94 (Z isomer. 2H, t, J 5.9
Hz), 4.07 (E isomer. 2H, t, J 5.9 Hz), 6.68 (Z isomer. 2H, d, J
9.7 Hz), 6.76 (E isomer. 2H, d, J 9.3 Hz), 6.86-7.36 (Z and E
isomers. 10H, m). IR (KBr film) ν
max
/cm-1: 3081, 3056, 2974,
2826, 2770, 1611, 1509, 1238, 1044. GC-MS (EI) m/z: Z
isomer, 371(4%), 72 (24%), 58(100%); E isomer, 371(3%),
72 (24%), 58(100%). (the diastereoisomeric ratio was
determined by capillary GC analysis and the configuration of
the major diastereoisomer established by comparison of the
NMR data of the synthetic mixture with an authentic sample
of (Z)-tamoxifen (1).
Obtention of an authentic sample of (Z)-tamoxifen [N,N-
dimethyl-2[4-(1,2-diphenyl-but-1-en-1-yl)phenoxy]-1-
ethylamine], (1)4
Two capsules of Nolvadex® (each containing 10 mg of
(Z)-tamoxifen) was dissolved in water (10 mL) and 10%
aqueous ammonium hydroxide was added until pH 9. The
aqueous phase was extracted with Et2O (5 x 5mL) and the
combined organic phase was extracted with brine, dried
over anhydrous MgSO4 and concentrated under reduced
pressure. The solid was recristallized from MeOH/H2O 5%
affording (Z)-tamoxifen (1) (8 mg) as a white solid, mp:
95.8-96.3 ºC. 1H-NMR (500 MHz, CDCl3) δ 0.92 (3H, t, J
7.3 Hz), 2.29 (6H, s), 2.45 (2H, q, J 7.3 Hz), 2.65 (2H, t, J
5.8 Hz), 3.93 (2H, t, J 5.8 Hz), 6.68 (2H, d, J 9.5 Hz), 6.78
(2H, d, J 9.5 Hz), 7.08-7.28 (10H, m).13C-NMR (125 MHz,
CDCl3) δ 13.6 (CH3), 29.0 (CH2), 45.8 (CH3), 58.2 (CH2),
65.5 (CH2), 113.4 (C), 126.0 (C), 126.5 (CH), 127.8 (CH),
128.1 (C), 129.7 (C), 131.8 (CH), 135.6 (CH), 138.2 (CH),
141.3 (CH), 142.4 (CH), 143.8 (C), 156.7 (C). IR (KBr
film) ν
max
/cm-1: 3055, 2979, 2925, 2813, 2769, 1606, 1509,
1240, 1035, 707. GC-MS (EI) m/z 371(5%), 58(100%).
General procedure for the palladium-catalysed double
cross-coupling of (E)-vinylic dibromides 11a-e with PhZnCl
(Table 2)
To a solution of bromobenzene (8.0 equiv.) in dry THF
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at –78 ºC was added butyllithium (8.2 equiv.). After 15 min.,
a solution of ZnCl2 (9.0 equiv.) in dry THF was added then
the temperature was allowed to room temperature. After 30
min, a solution of vinylic dibromide 11a-e (1.0 equiv.) and
tetrakis(triphenylphosphine)palladium(0) (0.1 equiv.) in dry
THF was added and the conditions described in Table 2 were
followed. The reaction was periodically monitored by GC
analysis of samples previously hydrolysed with an aqueous
NH4Cl solution and extracted with Et2O. After completion
of the reaction, the mixture was treated at room temperature
with an aqueous NH4Cl solution and extracted with Et2O.
The organic was extracted with brine and dried over
anhydrous MgSO4. The crude mixture was chromatographed
on silica gel to afford 14a-e.
(2Z)-2,3-diphenylprop-2-en-1-ol, (14a).21 Yellow oil.
1H-NMR (300 MHz, CDCl3) δ 1.72 (1H, s), 4.45 (2H, s),
7.00-7.29 (11H, m). IR (KBr film) ν
max
/cm-1: 3361, 3053,
3020, 2922, 2852, 1599, 1489, 1024.
(Z)-2,3-diphenylbut-2-en-1-ol, (14b). 11 Yellow oil. 1H-
NMR (300 MHz, CDCl3) δ 1.38 (1H, s), 2.13 (3H, s), 4.53
(2H, s), 6.88-7.22 (10H, m). 13C-NMR (75 MHz, CDCl3) δ
21.0, 63.8, 126.1, 126.3, 127.7, 127.9, 128.8, 129.7, 136.5,
137.2, 140.7, 143.6. IR (KBr film) ν
max
/cm-1: 3345, 3057,
3023, 2920, 2862, 1601, 1489, 1020, 991. GC-MS (EI) m/
z 224(8%), 206(14%), 115(47%), 105(100%), 91(77%),
77(25%).
1,1',1'’-ethene-1,1,2-triyltribenzene, (14c).6 White
solid, mp: 71.2-72.5 ºC. 1H-NMR (300 MHz, CDCl3) δ
6.96-7.32 (16H, m). 13C-NMR (75 MHz, CDCl3) δ 126.7,
127.4, 127.5, 128.0, 128.2, 128.2, 128.6, 129.5, 130.4,
137.4, 140.4, 142.6, 143.4. IR (KBr film) ν
max
/cm-1: 3078,
3057, 3022, 2824, 1592, 1493, 1444, 1076, 1030.
1,1',1'’-but-1-ene-1,1,2-triyltribenzene, (14d). 6 White
solid, mp: 78.9-79.5 ºC. 1H-NMR (300 MHz, CDCl3) δ
0.94 (3H, t, J 7.6 Hz), 2.48 (2H, q, J 7.5 Hz), 6.85-7.36
(15H, m). 13C-NMR (75 MHz, CDCl3) δ 13.6, 29.0, 125.6,
126.0, 126.5, 127.2, 127.7, 128.0, 129.3, 129.6, 130.6,
138.7, 142.1, 142.8, 143.4. IR (KBr film) ν
max
/cm-1: 3078,
3055, 3020, 2966, 2927, 2870, 1597, 1493, 1442, 1072,
1030, 775, 698.
1,1',1'’,1'’’-ethene-1,1,2,2-tetrayltetrabenzene, (14e).22
White solid, mp: 224.1-225.3 ºC. 1H-NMR (500 MHz,
CDCl3) δ 7.02-7.48 (20H, m). 13C-NMR (125 MHz, CDCl3)
δ 127.4, 130.4, 137.4, 143.4. IR (KBr film) ν
max
/cm-1: 3086,
3047, 2842, 1591, 1490, 1441, 1030.
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